https://www.selleckchem.com/pr....oducts/gambogic-acid
003) and OS (P=0.02) compared to patients with exon 21 mutations. Irrespective of specific exon mutations, a statistically significant positive linear correlation was found between EGFR-aVAF of tumoral tissue and PFS (r=0.319; P=0.002). High (≥70%) EGFR-aVAF was an independent predictor of longer PFS [ low (70%) EGFR-aVAF; median PFSs were 52 26 weeks, respectively; P0.001]. Additionally, patients with high EGFR-aVAF also had significantly improved OS than those with low EGFR-aVAF (P=0.011). Our study suggests that high (≥
Like
Comment
Share
